OrbiMed Advisors LLC's Form 4 filing
Compass Therapeutics, Inc. (CMPX) · filed May 13, 2022
- Accession no.
- 0000947871-22-000567
- Filed
- May 13, 2022, 5:45 PM ET
- Trade date
- May 11-13, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $420.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | Director, 10% Owner |
| OrbiMed Capital GP V LLCCIK 0001615374 | Director, 10% Owner |
| OrbiMed Genesis GP LLCCIK 0001808744 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2022 | Common Stock | PPurchaseAcquired | +64,700 | $1.79 | +$115,813 | 14,690,178 | Indirect | Duplicate filing |
| May 12, 2022 | Common Stock | PPurchaseAcquired | +97,094 | $2.35 | +$228,170.9 | 14,787,272 | Indirect | Duplicate filing |
| May 13, 2022 | Common Stock | PPurchaseAcquired | +30,722 | $2.49 | +$76,497.78 | 14,817,994 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.